NCT02116933

Grafting of Autologous Adipose Stromal Cell Trial

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Tower Outpatient Surgical Center · Academic / Other
• Sex: Female
• Age: 21 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Grafting of autologous stromal cell trial is a prospective study comparing routine fat grafting versus stromal vascular fraction enriched fat grafting.

Detailed description

The purpose of this study is to objectively compare outcomes between autologous fat grafting breast augmentation and stromal vascular fraction enhanced autologous fat grafting for cosmetic breast augmentation in a carefully designed study. Patients will be given the option of participating in one of two studies: 1. A small, level I study will compare AFG to SVF-enriched AFG in the same patient. One breast will be treated with AFG alone (control) and the other breast with SVF-enriched AFG (experimental). 2. A larger, level II study comparing AFG to SVF-enriched AFG in different patients. The patient will either receive AFG alone in both breasts or SVF-enhanced AFG in both breasts.

Conditions

• Micromastia

Interventions

Type	Name	Description
PROCEDURE	Adipose Derived Stem Cells	Adipose derived stem cells harvested from autologous lipoaspirate
PROCEDURE	SVF Enriched Autologous Fat Grafting	Cell assisted lipotransfer

Timeline

• Start date: 2013-03-01
• Primary completion: 2016-03-01
• Completion: 2016-03-01
• First posted: 2014-04-17
• Last updated: 2015-05-13

Locations

1 site across 1 country: United States